FibroGen Inc. has appointed Thane Wettig as Interim Chief Executive Officer succeeding Enrique Conterno who resigned from the position and the Board but will stay as Special Advisor until August 8, 2023. As part of Wettig's appointment, he will receive an additional monthly salary boost of $10,000 on top of his annual base salary of $545,000. He will also remain as Chief Commercial Officer.